$NXPI
NXP Semiconductors NV Stock $nxpi

$nxpi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000141344724000038 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$3.127B	$3.126B
YoY Change	0.19%
Cost Of Revenue	$1.335B	$1.343B
YoY Change	-1.18%
Gross Profit	$1.792B	$1.783B
YoY Change	1.24%
Gross Profit Margin	57.31%	57.04%
Selling, General & Admin	$270.0M	$306.0M
YoY Change	-3.57%
% of Gross Profit	15.07%	17.16%
Research & Development	$594.0M	$564.0M
YoY Change	2.95%
% of Gross Profit	33.15%	31.63%
Depreciation & Amortization	$213.0M	$235.0M
YoY Change	-24.73%
% of Gross Profit	11.89%	13.18%
Operating Expenses	$892.0M	$921.0M
YoY Change	-5.31%
Operating Profit	$896.0M	$856.0M
YoY Change	8.61%
Interest Expense	$97.00M	$105.0M
YoY Change	-12.61%
% of Operating Profit	10.83%	12.27%
Other Income/Expense, Net	-$75.00M	-$70.00M
YoY Change	-8.54%
Pretax Income	$821.0M	$786.0M
YoY Change	10.5%
Income Tax	$154.0M	$141.0M
% Of Pretax Income	18.76%	17.94%
Net Earnings	$658.0M	$639.0M
YoY Change	6.99%
Net Earnings / Revenue	21.04%	20.44%
Basic Earnings Per Share	$2.58	$2.49
Diluted Earnings Per Share	$2.54	$2.47
COMMON SHARES
Basic Shares Outstanding	255.7M shares	256.5M shares
Diluted Shares Outstanding	258.7M shares	259.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.866B	$2.917B
YoY Change	-27.24%
Cash & Equivalents	$2.859B	$2.908B
Short-Term Investments	$7.000M	$9.000M
Other Short-Term Assets	$546.0M	$603.0M
YoY Change	41.09%
Inventory	$2.148B	$2.102B
Prepaid Expenses
Receivables	$927.0M	$881.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.880B	$6.894B
YoY Change	-6.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.289B	$3.304B
YoY Change	5.32%
Goodwill	$9.941B	$9.945B
YoY Change	-0.08%
Intangibles
YoY Change
Long-Term Investments	$117.0M	$120.0M
YoY Change	13.59%
Other Assets	$2.290B	$2.338B
YoY Change	9.31%
Total Long-Term Assets	$16.32B	$16.43B
YoY Change	-0.36%
TOTAL ASSETS
Total Short-Term Assets	$6.880B	$6.894B
Total Long-Term Assets	$16.32B	$16.43B
Total Assets	$23.20B	$23.32B
YoY Change	-2.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$929.0M	$954.0M
YoY Change	-7.29%
Accrued Expenses	$402.0M	$502.0M
YoY Change	-18.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$499.0M	$0.00
YoY Change	-50.0%
Total Short-Term Liabilities	$3.112B	$2.928B
YoY Change	-26.13%
LONG-TERM LIABILITIES
Long-Term Debt	$9.681B	$10.18B
YoY Change	-4.8%
Other Long-Term Liabilities	$1.003B	$1.009B
YoY Change	-5.11%
Total Long-Term Liabilities	$10.74B	$11.24B
YoY Change	-4.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.112B	$2.928B
Total Long-Term Liabilities	$10.74B	$11.24B
Total Liabilities	$13.85B	$14.17B
YoY Change	-10.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.036B	-$2.421B
YoY Change	-44.25%
Common Stock	$14.79B	$14.68B
YoY Change	3.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.018B	$8.829B
YoY Change
Total Liabilities & Shareholders Equity	$23.20B	$23.32B
YoY Change	-2.26%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$658.0M	$639.0M
YoY Change	6.99%
Depreciation, Depletion And Amortization	$213.0M	$235.0M
YoY Change	-24.73%
Cash From Operating Activities	$761.0M	$851.0M
YoY Change	20.41%
INVESTING ACTIVITIES
Capital Expenditures	$240.0M	$226.0M
YoY Change	-4.38%
Acquisitions
YoY Change
Other Investing Activities	$1.000M	-$16.00M
YoY Change	-101.72%
Cash From Investing Activities	-$239.0M	-$274.0M
YoY Change	-31.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-567.0M	-$1.528B
YoY Change	186.36%
NET CHANGE
Cash From Operating Activities	761.0M	$851.0M
Cash From Investing Activities	-239.0M	-$274.0M
Cash From Financing Activities	-567.0M	-$1.528B
Net Change In Cash	-45.00M	-$954.0M
YoY Change	-152.94%
FREE CASH FLOW
Cash From Operating Activities	$761.0M	$851.0M
Capital Expenditures	$240.0M	$226.0M
Free Cash Flow	$521.0M	$625.0M
YoY Change	36.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1343000000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1351000000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1783000000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1770000000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	564000000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	577000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	306000000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	280000000	usd
CY2024Q1	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	51000000	usd
CY2023Q2	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	85000000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	921000000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	942000000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-6000000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	856000000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	825000000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	nxpi	Other Financial Income Expense OtherFinancialIncomeExpense	-70000000	usd
CY2023Q2	nxpi	Other Financial Income Expense OtherFinancialIncomeExpense	-82000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	786000000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	743000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	141000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-1000000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-2000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	639000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	615000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.37
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.35
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256567000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259576000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258954000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261210000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-8000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	3000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-38000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	19000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	598000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	645000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	8000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	593000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	637000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2908000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3862000000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	400000000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	409000000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	881000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	894000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2102000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	603000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	565000000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6894000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7864000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2338000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2289000000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5783000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5660000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3304000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1326000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	839000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	922000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	9945000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9955000000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	16426000000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	16489000000	usd
CY2024Q1	us-gaap	Assets Assets	23320000000	usd
CY2023Q4	us-gaap	Assets Assets	24353000000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	954000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1164000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	68000000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	92000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1906000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	0	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	1000000000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2928000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4111000000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10178000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	9000000	usd
CY2023Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	9000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	46000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	44000000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1009000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1054000000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11242000000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11282000000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	14170000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	15393000000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	321000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	316000000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	56000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	56000000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14619000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14501000000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	18424194	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17329585	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3469000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3210000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	44000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	90000000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2421000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2793000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8829000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8644000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9150000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23320000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24353000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	235000000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	283000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	115000000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	99000000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2000000	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2000000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1000000	usd
CY2024Q1	nxpi	Results Related To Equity Method Investments ResultsRelatedToEquityMethodInvestments	-1000000	usd
CY2023Q2	nxpi	Results Related To Equity Method Investments ResultsRelatedToEquityMethodInvestments	-2000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-64000000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-62000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	25000000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	138000000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-32000000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	196000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-102000000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	52000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-6000000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	33000000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3000000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5000000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	851000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	632000000	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32000000	usd
CY2023Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	226000000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	251000000	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2000000	usd
CY2023Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9000000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	34000000	usd
CY2023Q2	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	58000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	5000000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-274000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-351000000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1000000000	usd
CY2023Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	261000000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	219000000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37000000	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	303000000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11000000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
CY2023Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1528000000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-198000000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-954000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	85000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3862000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3845000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2908000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3930000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	38000000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	54000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	198000000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	294000000	usd
CY2024Q1	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	2000000	usd
CY2023Q2	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
CY2024Q1	nxpi	Written Down Value Of Assets Sold WrittenDownValueOfAssetsSold	0	usd
CY2023Q2	nxpi	Written Down Value Of Assets Sold WrittenDownValueOfAssetsSold	0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	223000000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	176000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	118000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	37000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	303000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	260000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9150000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7740000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	264000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8248000000	usd
CY2024Q1	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2023Q2	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3126000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3121000000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	145000000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	160000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	235000000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283000000	usd
CY2024Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	50000000	usd
CY2023Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	42000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	105000000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	111000000	usd
CY2024Q1	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-15000000	usd
CY2023Q2	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-13000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-70000000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	639000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	615000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256567000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259576000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	172000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	206000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2215000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1428000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2387000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1634000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258954000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261210000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.37
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.35
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2908000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3862000000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	104000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	113000000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1580000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1633000000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	418000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	388000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2102000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	198000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	189000000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	9000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12000000	usd
CY2024Q1	us-gaap	Other Investments OtherInvestments	66000000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	55000000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	120000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q1	us-gaap	Investments Investments	195000000	usd
CY2023Q4	us-gaap	Investments Investments	168000000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	120000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q1	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-2000000	usd
CY2023Q2	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-2000000	usd
CY2024Q1	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	1000000	usd
CY2023Q2	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	502000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	500000000	usd
CY2024Q1	us-gaap	Customer Funds CustomerFunds	339000000	usd
CY2023Q4	us-gaap	Customer Funds CustomerFunds	280000000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	168000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	260000000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	261000000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	637000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	644000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1906000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-53000000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-4000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-46000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	260000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	263000000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	101000000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	8000000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	31000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	0	usd
CY2024Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1000000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	77000000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	77000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	68000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	9000000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	21000000	usd
CY2023Q2	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	3000000	usd
CY2024Q1	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	7000000	usd
CY2023Q2	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	18000000	usd
CY2024Q1	nxpi	Estimated Effective Income Tax Rate EstimatedEffectiveIncomeTaxRate	0.175
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2024Q1	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-139000000	usd
CY2023Q2	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-126000000	usd
CY2024Q1	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-2000000	usd
CY2023Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	8000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	141000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179
CY2024Q1	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-2000000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2165000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1326000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10250000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11250000000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	72000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	75000000	usd
CY2024Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10178000000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11175000000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10178000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	4118000000	usd
CY2024Q1	nxpi	Number Of Birth Defect Individuals NumberOfBirthDefectIndividuals	21	individual
CY2024Q1	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	95000000	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	112000000	usd
CY2024Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2024Q1	nxpi	Insurance Reimbursement Of Claims Potential Maximum Exposure InsuranceReimbursementOfClaimsPotentialMaximumExposure	70000000	usd

Files In Submission

Name	View Source	Status
0001413447-24-000038-index-headers.html	Edgar Link	pending
0001413447-24-000038-index.html	Edgar Link	pending
0001413447-24-000038.txt	Edgar Link	pending
0001413447-24-000038-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxpi-20240331.htm	Edgar Link	pending
nxpi-20240331.xsd	Edgar Link	pending
nxpi-20240331_g1.jpg	Edgar Link	pending
nxpi-20240331_g2.jpg	Edgar Link	pending
nxpi-20240331_g3.jpg	Edgar Link	pending
nxpi-20240331_g4.jpg	Edgar Link	pending
nxpi-20240331_g5.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nxpi-20240331_cal.xml	Edgar Link	unprocessable
nxpi-20240331_def.xml	Edgar Link	unprocessable
nxpi-20240331_g6.jpg	Edgar Link	pending
nxpi-20240331_g7.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
nxpi-20240331_pre.xml	Edgar Link	unprocessable
nxpi-20240331_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nxpi-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXPI
NXP Semiconductors NV Stock $nxpi

2024 Q2 Form 10-Q Financial Statement

#000141344724000038 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPI NXP Semiconductors NV Stock $nxpi

2024 Q2 Form 10-Q Financial Statement

#000141344724000038 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPI
NXP Semiconductors NV Stock $nxpi